These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 12925056)
1. Alveolar bone loss associated with glucose tolerance in Japanese men. Marugame T; Hayasaki H; Lee K; Eguchi H; Matsumoto S Diabet Med; 2003 Sep; 20(9):746-51. PubMed ID: 12925056 [TBL] [Abstract][Full Text] [Related]
2. The extent of alveolar bone loss is associated with impaired glucose tolerance in Japanese men. Saito T; Murakami M; Shimazaki Y; Matsumoto S; Yamashita Y J Periodontol; 2006 Mar; 77(3):392-7. PubMed ID: 16512753 [TBL] [Abstract][Full Text] [Related]
3. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose. Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644 [TBL] [Abstract][Full Text] [Related]
4. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk? Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766 [TBL] [Abstract][Full Text] [Related]
5. The risk of type 2 diabetes mellitus according to 2-h plasma glucose level: The Korean Genome and Epidemiology Study (KoGES). Park SK; Ryoo JH; Oh CM; Choi JM; Choi YJ; Lee KO; Jung JY Diabetes Res Clin Pract; 2018 Dec; 146():130-137. PubMed ID: 28951335 [TBL] [Abstract][Full Text] [Related]
6. Relation of impaired glucose tolerance and diabetes mellitus to colorectal adenomas in Japan. Marugame T; Lee K; Eguchi H; Oda T; Shinchi K; Kono S Cancer Causes Control; 2002 Dec; 13(10):917-21. PubMed ID: 12588087 [TBL] [Abstract][Full Text] [Related]
7. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance]. Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059 [TBL] [Abstract][Full Text] [Related]
8. Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran. Janghorbani M; Amini M Diabetes Res Clin Pract; 2015 Jun; 108(3):414-22. PubMed ID: 25814432 [TBL] [Abstract][Full Text] [Related]
9. Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects. Miyazaki Y; Akasaka H; Ohnishi H; Saitoh S; DeFronzo RA; Shimamoto K Hypertens Res; 2008 Jul; 31(7):1357-63. PubMed ID: 18957806 [TBL] [Abstract][Full Text] [Related]
10. Impaired glucose tolerance is not associated with lipid intolerance. Henkel E; Temelkova-Kurktschiev T; Koehler C; Pietzsch J; Leonhardt W; Hanefeld M Diabetes Nutr Metab; 2002 Apr; 15(2):84-90. PubMed ID: 12059096 [TBL] [Abstract][Full Text] [Related]
11. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile. Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375 [TBL] [Abstract][Full Text] [Related]
12. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study. Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S; J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736 [TBL] [Abstract][Full Text] [Related]
13. [Prevalence of type II diabetes mellitus in population of Krakow]. Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study. Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208 [TBL] [Abstract][Full Text] [Related]
15. [A study comparing the prevalence of urinary albumin excretion and microalbuminuria in pre-diabetes subjects]. Wang XL; Lu JM; Pan CY; Tian H Zhonghua Nei Ke Za Zhi; 2004 Mar; 43(3):170-3. PubMed ID: 15059368 [TBL] [Abstract][Full Text] [Related]
16. Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study. Salomaa VV; Tuomilehto J; Jauhiainen M; Korhonen HJ; Stengård J; Uusitupa M; Pitkanen M; Penttila I Diabetes Care; 1992 May; 15(5):657-65. PubMed ID: 1516486 [TBL] [Abstract][Full Text] [Related]
17. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Jensen CC; Cnop M; Hull RL; Fujimoto WY; Kahn SE; Diabetes; 2002 Jul; 51(7):2170-8. PubMed ID: 12086947 [TBL] [Abstract][Full Text] [Related]
18. Factors determining normalization of glucose intolerance in middle-aged Swedish men and women: a 8-10-year follow-up. Alvarsson M; Hilding A; Ostenson CG Diabet Med; 2009 Apr; 26(4):345-53. PubMed ID: 19388963 [TBL] [Abstract][Full Text] [Related]
19. Area under the curve during OGTT in first-degree relatives of diabetic patients as an efficient indicator of future risk of type 2 diabetes and prediabetes. Feizi A; Meamar R; Eslamian M; Amini M; Nasri M; Iraj B Clin Endocrinol (Oxf); 2017 Dec; 87(6):696-705. PubMed ID: 28793372 [TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study. Bianchi C; Miccoli R; Bonadonna RC; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Alviggi L; Gnasso A; Consoli A; Cavalot F; Cavallo MG; Leonetti F; Giaccari A; Del Prato S; Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):699-705. PubMed ID: 21291660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]